金域医学 (603882)
Guangzhou Kingmed Diagnostics Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 46325.83
- Circulating A-Shares(W): 46013.46
- Earnings Per Share(RMB): -0.1700
- Net Assets Per Share(RMB): 14.7400
- Operating Revenue(W RMB): 453815.14
- Total Profit(W RMB): -8211.78
- **Net Profit Attributable to Parent(W RMB) **: -7960.95
- Net Profit Growth Rate(%): -184.84
- Weighted Return on Equity(%): -1.1400
- Operating Cash Flow Per Share(RMB): 1.4500
- Undistributed Profit Per Share(RMB): 10.6477
- Capital Reserve Per Share(RMB): 2.5248
2. Main Business
The main business covers:
- Providing medical testing and pathological diagnosis outsourcing services to various medical institutions (including hospitals, maternal and child health hospitals, health centers, etc.)
3. Company Basic Information
- Company Name: Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Listing Date: 2017-09-08
- Industry: Healthcare
- Address: No. 10, Spiral 3rd Road, Guangzhou International Bio-Island, Guangdong Province
- Website: https://www.kingmed.com.cn/
- Company Profile: The company was established by Liang Yaoming and 11 other shareholders as promoters through the overall transformation of Kingmed Limited into a joint stock company. On June 11, 2015, Kingmed Limited held a shareholders' meeting and resolved to convert the company's audited net assets of 323.5534 million yuan as of March 31, 2015 into 190 million shares of the joint stock company at a ratio of 1:0.587229. The portion of net assets exceeding the registered capital, 133.5534 million yuan, was used as the capital reserve of the joint stock company. The capital contributions of the 12 promoter shareholders during this transformation were verified by Lixin Certified Public Accountants on July 15, 2015, and the business license was issued by Guangzhou Administration for Industry and Commerce on July 24, 2015.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 3550.57 | 7.72 |
| 2 | Guochuang Kaiyuan Equity Investment Fund (Limited Partnership) | General Legal Person | 3088.09 | 6.71 |
| 3 | Guangzhou Xinmanyu Investment Consulting Partnership (Limited Partnership) | General Legal Person | 2859.01 | 6.21 |
| 4 | Guangzhou Shengyufang Investment Consulting Partnership (Limited Partnership) | General Legal Person | 2100.00 | 4.56 |
| 5 | Guangzhou Shengboyu Investment Consulting Partnership (Limited Partnership) | General Legal Person | 1929.88 | 4.19 |
| 6 | Guangzhou Ruizhi Investment Consulting Partnership (Limited Partnership) | General Legal Person | 1490.29 | 3.24 |
| 7 | Huabao CSI Medical ETF | Fund | 787.86 | 1.71 |
| 8 | China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Renqiao Zeyuan Stock Private Securities Investment Fund | Private Securities Investment Fund | 586.42 | 1.27 |
| 9 | Ruizhong Life Insurance Co., Ltd. - Own Funds | Insurance | 522.17 | 1.13 |
| 10 | Great Wall Consumption Growth Mixed Securities Investment Fund Class A | Fund | 130.05 | 0.28 |
5. Concept Sectors
- Intelligent Machines
- Gene Concept
- Immunotherapy
- Artificial Intelligence
- Tencent Concept
- Cold Chain Logistics
- Helicobacter Pylori
- Hepatitis Concept
- AIGC Concept
- Data Elements
- AI Agents
- DeepSeek
- AI Healthcare
- Margin Trading
- Consecutive Losses
- Heavy Northbound Holdings
- New Private Placements
- Guozheng Services
Remarks
- Data update date: 2025-11-07
- Data source: Public market information